Article
Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.
Cancer biology & therapy - 1 Apr 2009
Golding Sarah E, Morgan Rhiannon N, Adams Bret R, Hawkins Amy J, Povirk Lawrence F, Valerie Kristoffer
Abstract excerpt
The epidermal growth factor receptor (EGFR) is frequently dysregulated in malignant glioma that leads to increased resistance to cancer therapy. Upregulation of wild type or expression of mutant EGFR is associated with tumor radioresistance and poor clinical outcome. EGFR variant III (EGFRvIII) is the most common EGFR mutation in malignant glioma. Radioresistance is thought to be, at least in part, the result of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
